158 related articles for article (PubMed ID: 14723365)
1. Three cases of viridans group streptococcal bacteremia in children with febrile neutropenia and literature review.
Danilatou V; Mantadakis E; Galanakis E; Christidou A; Stiakaki E; Kalmanti M
Scand J Infect Dis; 2003; 35(11-12):873-6. PubMed ID: 14723365
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia.
Han SB; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK
Infection; 2013 Oct; 41(5):917-24. PubMed ID: 23640200
[TBL] [Abstract][Full Text] [Related]
3. Viridans streptococcal bacteremia-related encephalopathy in childhood with malignancy.
Sato Y; Okuya M; Hagisawa S; Matsushita T; Fukushima K; Kurosawa H; Sugita K; Arisaka O
Pediatr Hematol Oncol; 2011 Feb; 28(1):24-30. PubMed ID: 21247349
[TBL] [Abstract][Full Text] [Related]
4. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.
Ahmed R; Hassall T; Morland B; Gray J
Pediatr Hematol Oncol; 2003 Sep; 20(6):439-44. PubMed ID: 14631617
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients].
Ombandza-Moussa E; Schlegel L; Vekhoff A; Gerbal R; Marie JP; Bouvet A
Pathol Biol (Paris); 2002 Apr; 50(3):169-77. PubMed ID: 11980330
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and antimicrobial susceptibilities of viridans streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: a comparison between adults and children.
Han SB; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK
BMC Infect Dis; 2013 Jun; 13():273. PubMed ID: 23773209
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
9. Viridans group streptococci in febrile neutropenic cancer patients: what should we fear?
Freifeld AG; Razonable RR
Clin Infect Dis; 2014 Jul; 59(2):231-3. PubMed ID: 24755859
[No Abstract] [Full Text] [Related]
10. Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience.
Radocha J; Paterová P; Zavřelová A; Víšek B; Gabalec F; Žemličková H; Žák P
Folia Microbiol (Praha); 2018 Mar; 63(2):141-146. PubMed ID: 28776170
[TBL] [Abstract][Full Text] [Related]
11. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.
Bochud PY; Eggiman P; Calandra T; Van Melle G; Saghafi L; Francioli P
Clin Infect Dis; 1994 Jan; 18(1):25-31. PubMed ID: 8054434
[TBL] [Abstract][Full Text] [Related]
12. Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital.
Nielsen MJ; Claxton S; Pizer B; Lane S; Cooke RPD; Paulus S; Carrol ED
Medicine (Baltimore); 2016 Mar; 95(9):e2952. PubMed ID: 26945409
[TBL] [Abstract][Full Text] [Related]
13. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients.
Gassas A; Grant R; Richardson S; Dupuis LL; Doyle J; Allen U; Abla O; Sung L
J Clin Oncol; 2004 Apr; 22(7):1222-7. PubMed ID: 15051769
[TBL] [Abstract][Full Text] [Related]
14. Viridans-group streptococcal infections in immunocompromised hosts.
Shenep JL
Int J Antimicrob Agents; 2000 Mar; 14(2):129-35. PubMed ID: 10720803
[TBL] [Abstract][Full Text] [Related]
15. Penicillin resistance in viridans streptococcal bacteremia is related with high mortality.
Docze A; Mraz M; Grey E; Bucko E; Korcova J; Svetlansky I; Sabo Z; Krcméry V
Scand J Infect Dis; 2003; 35(11-12):916-7. PubMed ID: 14723386
[No Abstract] [Full Text] [Related]
16. Viridans streptococci bacteremia in children with malignancy: relevance of species identification and penicillin susceptibility.
Husain E; Whitehead S; Castell A; Thomas EE; Speert DP
Pediatr Infect Dis J; 2005 Jun; 24(6):563-6. PubMed ID: 15933573
[TBL] [Abstract][Full Text] [Related]
17. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance.
Bruckner L; Gigliotti F
Semin Pediatr Infect Dis; 2006 Jul; 17(3):153-60. PubMed ID: 16934710
[TBL] [Abstract][Full Text] [Related]
18. Infective endocarditis in neutropenic patients with viridans streptococci bacteraemia.
Beteille E; Guarana M; Nucci M
Clin Microbiol Infect; 2018 Aug; 24(8):916-917. PubMed ID: 29559393
[No Abstract] [Full Text] [Related]
19. Infection of the post-pneumonectomy space after dental procedures.
Dietl CA; Mehran RJ
J Cardiovasc Surg (Torino); 2004 Oct; 45(5):521-2. PubMed ID: 15736578
[No Abstract] [Full Text] [Related]
20. In vitro inferiority of ceftazidime compared with other beta-lactams for viridans group Streptococcus bacteremia in pediatric oncology patients: implications for antibiotic choices.
Paulus S; Dobson S; Rassekh S; Blondel-Hill E
J Pediatr Hematol Oncol; 2009 Apr; 31(4):267-9. PubMed ID: 19346878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]